Table 4 QMs Attainment at Baseline, Week 52 and Week 104 in the overall population
|  |  | CANA 100 mg (N = 483) | CANA 300 mg (N = 485) | GLIM (N = 482) | ||
|---|---|---|---|---|---|---|
Measure | Â | % | Difference vs. GLIM, % (95Â % Cl) | % | Difference vs. GLIM, % (95Â % Cl) | % |
A1C | ||||||
 <7.0 % | Baseline | 12.2 |  | 14.6 |  | 13.5 |
52 weeks | 53.6 | −2.3 (−8.8; 4.3) | 60.1 | 4.3 (−2.2; 10.8) | 55.7 | |
104 weeks | 42.5 | −1.4 (−7.9; 5.1) | 50.2 | 6.3 (−0.2; 12.9) | 43.9 | |
 <8.0 % (good control) | Baseline | 61.1 |  | 59.9 |  | 60.1 |
52 weeks | 88.7 | 4.3 (−0.2; 8.9) | 89.2 | 4.9 (0.4; 9.4) | 84.4 | |
104Â weeks | 83.9 | 7.9 (2.7; 13.2) | 84.6 | 8.6 (3.4; 13.9) | 75.9 | |
 >9.0 % (poor control) | Baseline | 6.5 |  | 7.2 |  | 7.2 |
52 weeks | 1.9 | −2.1 (−4.5; 0.2) | 1.7 | −2.3 (−4.7; −0.0) | 4.0 | |
104 weeks | 2.5 | −2.8 (−5.4; −0.1) | 1.9 | −3.4 (−5.9; −0.8) | 5.3 | |
Blood pressure | ||||||
 <140/90 mm Hg | Baseline | 74.1 |  | 74.2 |  | 75.0 |
52Â weeks | 83.7 | 10.6 (5.2; 16.0) | 85.4 | 12.3 (7.0; 17.6) | 73.1 | |
104 weeks | 79.6 | 5.4 (−0.1; 10.9) | 84.2 | 10.0 (4.7; 15.3) | 74.2 | |
Body mass index and body weight | ||||||
 ≤30 kg/m2 | Baseline | 44.5 |  | 46.3 |  | 48.1 |
52Â weeks | 57.4 | 10.5 (4.0; 17.1) | 55.6 | 8.8 (2.2; 15.3) | 46.9 | |
104Â weeks | 57.3 | 10.2 (3.7; 16.7) | 54.8 | 7.7 (1.2; 14.2) | 47.1 | |
 ≥25 kg/m2 but ≥10 lb (4.5 kg) weight loss from baseline | Baseline |  |  |  |  |  |
52Â weeks | 27.1 | 20.2 (15.4; 25.0) | 34.6 | 27.7 (22.6; 32.7) | 6.9 | |
104Â weeks | 27.9 | 20.0 (15.1; 24.9) | 34.6 | 26.6 (21.5; 31.7) | 7.9 | |